Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 17;66(11):1798-1801.
doi: 10.1093/cid/ciy011.

Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children

Affiliations

Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children

Sylvia M LaCourse et al. Clin Infect Dis. .

Abstract

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A, Cumulative probability of death by urine LAM result among hospitalized HIV–infected children. * indicates adjusted for age, CD4%, and parent trial antiretroviral therapy treatment arm. B, Cumulative probability of death by urine LAM result among hospitalized HIV-infected children stratified by TB, HIV-related immunosuppression, and malnutrition status. Confirmed TB was that for which a bacterial confirmation was obtained with positive respiratory sample Xpert or culture result. Unconfirmed TB was that for which bacterial confirmation was not obtained and at least 2 of the following were present: suggestive symptoms of TB, chest X-ray consistent with TB, close TB exposure or immunologic evidence of Mycobacterium tuberculosis infection, TB treatment response. Unlikely TB was that not fitting in any of the TB diagnosis criteria. (Graham et al [7]). Severe immunosuppression was based on World Health Organization (WHO) age-specified CD4 cutoffs—CD4%: aged <12 months, <25%; aged 12–35 months, <20%; aged >36 months, <15%—or, in absence of CD4% data, CD4 count: aged <12 months, <1500 cells/µL; aged 12–35 months, <750 cells/µL; aged >36 months, <350 cells/µL (WHO 2007). Malnourished was based on WHO definitions of wasting with either weight-to-height z score <−2 or mid–upper arm circumference <12.5 cm. Abbreviations: aHR, adjusted hazard ratio; HIV, human immunodeficiency virus; HR, hazard ratio; LAM, lipoarabinomannan; PY, person-years; TB, tuberculosis.
Figure 1.
Figure 1.
A, Cumulative probability of death by urine LAM result among hospitalized HIV–infected children. * indicates adjusted for age, CD4%, and parent trial antiretroviral therapy treatment arm. B, Cumulative probability of death by urine LAM result among hospitalized HIV-infected children stratified by TB, HIV-related immunosuppression, and malnutrition status. Confirmed TB was that for which a bacterial confirmation was obtained with positive respiratory sample Xpert or culture result. Unconfirmed TB was that for which bacterial confirmation was not obtained and at least 2 of the following were present: suggestive symptoms of TB, chest X-ray consistent with TB, close TB exposure or immunologic evidence of Mycobacterium tuberculosis infection, TB treatment response. Unlikely TB was that not fitting in any of the TB diagnosis criteria. (Graham et al [7]). Severe immunosuppression was based on World Health Organization (WHO) age-specified CD4 cutoffs—CD4%: aged <12 months, <25%; aged 12–35 months, <20%; aged >36 months, <15%—or, in absence of CD4% data, CD4 count: aged <12 months, <1500 cells/µL; aged 12–35 months, <750 cells/µL; aged >36 months, <350 cells/µL (WHO 2007). Malnourished was based on WHO definitions of wasting with either weight-to-height z score <−2 or mid–upper arm circumference <12.5 cm. Abbreviations: aHR, adjusted hazard ratio; HIV, human immunodeficiency virus; HR, hazard ratio; LAM, lipoarabinomannan; PY, person-years; TB, tuberculosis.

References

    1. Jenkins HE, Yuen CM, Rodriguez CA, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17:285–95. - PMC - PubMed
    1. Shah M, Hanrahan C, Wang ZY, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev 2016; CD011420. - PMC - PubMed
    1. World Health Organization. The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV Available at: http://www.who.int/tb/publications/use-of-lf-lam-tb-hiv/en/. Accessed 21 September 2017.
    1. Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Med 2016; 14:53. - PMC - PubMed
    1. Njuguna IN, Cranmer LM, Otieno VO, et al. Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial. Lancet HIV 2018; 5:e12–22. - PMC - PubMed

Publication types

Associated data